ISPOR - GIR2 Noncompliance with Dosing Instructions And Gastrointestinal Outcomes Associated with Alendronate for Osteoporosis in A Large HMO

Full Text

GIR2 Noncompliance with Dosing Instructions And Gastrointestinal Outcomes Associated with Alendronate for Osteoporosis in A Large HMO

Abstract

Authors

B Ettinger JR Schein A Pressman

Back to Volume 1, Issue 1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now